Search research articles
Contact Us
Filters
Showing results (181-190 of 229) with videos related to
Page
of 23
Sort By:
Nature Communications
|
July 31, 2015
Chemically related 4,5-linked aminoglycoside antibiotics drive subunit rotation in opposite directions
Michael R Wasserman, Arto Pulk, Zhou Zhou, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases
I C Jacobson, P G Reddy, Z R Wasserman, et al.
Pediatric Obesity
|
March 22, 2012
Study design and baseline description of the BMI2 trial: reducing paediatric obesity in primary care practices
K Resnicow, F McMaster, S Woolford, et al.
Chemistry & Biology
|
February 14, 2002
Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR
Sharon J Archer, Daniel M Camac, Zhongren J Wu, et al.
The New England Journal of Medicine
|
February 19, 1981
Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy
P D Berk, J D Goldberg, M N Silverstein, et al.
The Journal of Pediatrics
|
April 9, 2019
Neonatal Intensive Care Variation in Medicaid-Insured Newborns: A Population-Based Study
David C Goodman, Cecilia Ganduglia-Cazaban, Luisa Franzini, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 26, 1999
Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production
R J Cherney, L Wang, D T Meyer, et al.
Structure (London, England : 1993)
|
November 13, 2010
Structural underpinnings of nitrogen regulation by the prototypical nitrogen-responsive transcriptional factor NrpR
Goragot Wisedchaisri, David M Dranow, Thomas J Lie, et al.
Medical and Pediatric Oncology
|
January 1, 1975
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma
J Cuttner, L R Wasserman, G Martz, et al.
Journal of Medicinal Chemistry
|
May 28, 2004
Sultam hydroxamates as novel matrix metalloproteinase inhibitors
Robert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 229) with videos related to
Sort By:
Page
of 23
Nature Communications
|
July 31, 2015
Chemically related 4,5-linked aminoglycoside antibiotics drive subunit rotation in opposite directions
Michael R Wasserman, Arto Pulk, Zhou Zhou, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases
I C Jacobson, P G Reddy, Z R Wasserman, et al.
Pediatric Obesity
|
March 22, 2012
Study design and baseline description of the BMI2 trial: reducing paediatric obesity in primary care practices
K Resnicow, F McMaster, S Woolford, et al.
Chemistry & Biology
|
February 14, 2002
Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR
Sharon J Archer, Daniel M Camac, Zhongren J Wu, et al.
The New England Journal of Medicine
|
February 19, 1981
Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy
P D Berk, J D Goldberg, M N Silverstein, et al.
The Journal of Pediatrics
|
April 9, 2019
Neonatal Intensive Care Variation in Medicaid-Insured Newborns: A Population-Based Study
David C Goodman, Cecilia Ganduglia-Cazaban, Luisa Franzini, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 26, 1999
Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production
R J Cherney, L Wang, D T Meyer, et al.
Structure (London, England : 1993)
|
November 13, 2010
Structural underpinnings of nitrogen regulation by the prototypical nitrogen-responsive transcriptional factor NrpR
Goragot Wisedchaisri, David M Dranow, Thomas J Lie, et al.
Medical and Pediatric Oncology
|
January 1, 1975
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma
J Cuttner, L R Wasserman, G Martz, et al.
Journal of Medicinal Chemistry
|
May 28, 2004
Sultam hydroxamates as novel matrix metalloproteinase inhibitors
Robert J Cherney, Ruowei Mo, Dayton T Meyer, et al.
Page
of 23